Veracyte, Inc.

Veracyte, Inc. - Enterprise Valueverified

VCYT

Price:

$46.885

Market Cap:

$3.74B

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.

Industry

Medical - Diagnostics & Research

IPO Date

2013-10-29

Stock Exchange

NASDAQ

Ticker

VCYT

The Enterprise Value as of August 2026 (TTM) for Veracyte, Inc. (VCYT) is 3.48B

According to Veracyte, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.48B. This represents a change of 14.20% compared to the average of 3.05B of the last 4 quarters.

Veracyte, Inc. (VCYT) Historical Enterprise Value (quarterly & annually)

How has VCYT Enterprise Value performed in the past?

The mean historical Enterprise Value of Veracyte, Inc. over the last ten years is 1.60B. The current 3.48B Enterprise Value has changed 21.60% with respect to the historical average. Over the past ten years (40 quarters), VCYT's Enterprise Value was at its highest in in the June 2026 quarter at 4.42B. The Enterprise Value was at its lowest in in the March 2018 quarter at 188.65M.

Quarterly (TTM)
Annual

Average

1.60B

Median

1.68B

Minimum

189.45M

Maximum

2.99B

Veracyte, Inc. (VCYT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Veracyte, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 176.63%

Maximum Annual Enterprise Value = 2.99B

Minimum Annual Increase = -41.03%

Minimum Annual Enterprise Value = 189.45M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20252.99B5.11%
20242.84B58.28%
20231.79B15.16%
20221.56B-41.03%
20212.64B16.50%
20202.27B98.56%
20191.14B176.63%
2018413.00M94.00%
2017212.89M12.37%
2016189.45M24.03%

Veracyte, Inc. (VCYT) Average Enterprise Value

How has VCYT Enterprise Value performed in the past?

The current Enterprise Value of Veracyte, Inc. (VCYT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

2.54B

5-year avg

2.36B

10-year avg

1.60B

Veracyte, Inc. (VCYT) Enterprise Value vs. Peers

How is VCYT’s Enterprise Value compared to its peers?

Veracyte, Inc.’s Enterprise Value is less than Kiniksa Pharmaceuticals International, plc (5.75B), greater than Zai Lab Limited (1.56B), greater than Legend Biotech Corporation (3.28B), less than Scholar Rock Holding Corporation (5.52B), greater than Disc Medicine, Inc. (2.95B), greater than Tarsus Pharmaceuticals, Inc. (2.59B), greater than IDEAYA Biosciences, Inc. (3.21B), less than Apellis Pharmaceuticals, Inc. (5.32B), less than Amicus Therapeutics, Inc. (4.82B), less than Adaptive Biotechnologies Corporation (4.18B),

Build a custom stock screener for Veracyte, Inc. (VCYT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Veracyte, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Veracyte, Inc. (VCYT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Veracyte, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Veracyte, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Veracyte, Inc. (VCYT)?

What is the 3-year average Enterprise Value for Veracyte, Inc. (VCYT)?

What is the 5-year average Enterprise Value for Veracyte, Inc. (VCYT)?

How does the current Enterprise Value for Veracyte, Inc. (VCYT) compare to its historical average?